KARL STORZ has acquired assets from Diaspective Vision, enhancing its imaging technology portfolio to improve surgical monitoring and outcomes.
Information on the Target
Diaspective Vision, a family-run MedTech firm based in Germany, has been at the forefront of innovation in spectral camera solutions for medical applications since its inception in 2015. The company specializes in the design and production of advanced hyperspectral and multispectral camera systems, which cater to various medical fields.
Some of Diaspective Vision's products have been marketed through KARL STORZ, reinforcing their synergy in the medical technology sector. Among their notable offerings is the TIVITA camera product line, which has garnered attention for its potential in enhancing surgical procedures.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
The German medical technology industry is recognized as one of the most advanced globally, driven by a robust research environment and a commitment to innovation. In recent years, the
Similar Deals
athagoras → DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH
2025
KARL STORZ
invested in
Diaspective Vision
in 2025
in a Other deal